Gilead Sciences CEO Daniel O'Day's 2021 pay rises 1% to $19M
Gilead Sciences reports 2021 executive compensation
By ExecPay News
Published: March 24, 2022
Gilead Sciences reported fiscal year 2021 executive compensation information on March 24, 2022.
In 2021, five executives at Gilead Sciences received on average a compensation package of $8.9M, a 2% decrease compared to previous year.
Average pay of disclosed executives at Gilead Sciences
Daniel P. O'Day, Chief Executive Officer, received $19M in total, which increased by 1% compared to 2020. 51% of O'Day's compensation, or $9.8M, was in stock awards. O'Day also received $3.4M in non-equity incentive plan, $3.4M in option awards, $1.7M in salary, as well as $994K in other compensation.
For fiscal year 2021, the median employee pay was $211,687 at Gilead Sciences. Therefore, the ratio of Daniel P. O'Day's pay to the median employee pay was 91 to one.
Johanna Mercier, Chief Commercial Officer, received a compensation package of $6.6M, which decreased by 16% compared to previous year. 40% of the compensation package, or $2.6M, was in stock awards.
Merdad V. Parsey, Chief Medical Officer, earned $6.5M in 2021, a 9% decrease compared to previous year.
Andrew D. Dickinson, Chief Financial Officer, received $6.5M in 2021, which increases by 11% compared to 2020.
Brett A. Pletcher, General Counsel, earned $5.6M in 2021, a 1% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on March 24, 2022.